K
KURA
Kura Oncology Inc
8.79
-0.03-0.34%After Hours: 8.83 +0.04 +0.46%17:18 04/08 EDT
OPEN/PREV CLOSE9.04/8.82
TODAY RANGE8.66-9.10
VOL1.05M
MARKET CAP776.42M
52 WEEK RANGE5.41-12.49
AVG VOL (3M)1.48M
% TURNOVER1.18%
TURNOVER--
P/E (TTM)-2.7655
% RANGE4.99%
EPS(TTM)-3.1784
P/E(FORWARD)-2.3254
P/B4.435
BVPS1.982
DIVIDEND--
P/S11.44
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP754.10M
SHARES OUTSTANDING88.33M
NEXT EARNINGS04/29-05/04
FREE FLOAT85.79M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Kura Oncology: Commercialization In AML Presents Asymmetric Upside
TipRanks·03/30 13:08
Syndax assumed with a Buy at Jefferies
Reuters·03/25 10:34
KURA ONCOLOGY INC <KURA.O>: MIZUHO CUTS TARGET PRICE TO $25 FROM $30
Reuters·03/25 08:01
U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources
Dow Jones·03/24 17:21
Kura Oncology Price Target Cut to $25.00/Share From $30.00 by Mizuho
Dow Jones·03/24 17:21
Kura Oncology Is Maintained at Outperform by Mizuho
Benzinga·03/24 17:11
Mizuho Maintains Outperform on Kura Oncology, Lowers Price Target to $25
TipRanks·03/24 15:07
Kura Oncology price target lowered to $25 from $30 at Mizuho
Seeking Alpha·03/18 18:12
Syndax Pharma: Two Drug Launches Fuel Transformational Growth
Dow Jones·03/13 20:37
Kura Oncology Price Target Cut to $15.00/Share From $16.00 by UBS
Dow Jones·03/13 20:37
Kura Oncology Is Maintained at Buy by UBS
Benzinga·03/13 20:27
UBS Maintains Buy on Kura Oncology, Lowers Price Target to $15
Same Industry
Name/Symbol
Change%
Price